BALTIMORE, MD / ACCESSWIRE / March 1, 2023 / Goldman Small Cap Research, a stock market research firm specializing in the small cap and microcap sectors, announced today that it has published a new research report on clinical stage biotech QSAM Biosciences, Inc. (OTCQB:QSAM), a developer of next-generation radiopharmaceutical therapy (RPT) for the treatment of cancer and other diseases. The report carries a price target. To view the new research report, along with previous reports and updates, disclosures and disclaimers, or to download the report in its entirety, please visit https://bit.ly/3kFfnRV.
Request a Demo
We'll get in touch to schedule a time that works best for you.